Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company, Announces Industry Veteran Dr. Simon Pedder has Joined the Board of Directors
Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio [...]
Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company Announces Selection of Therapeutic Targets for Immuno-Oncology Program
Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio [...]
Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. Poznansky has Guest Essay Published in the New York Times
Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. [...]
Voltron Therapeutics, Inc. Announces Positive Data from Animal Testing of Self-Assembling Vaccine in the Fight Against COVID-19
Voltron Therapeutics, Inc. Announces Positive Data from Animal [...]
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman.
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. [...]
Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy”
Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge [...]
Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19
Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling [...]
Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiary
Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore [...]
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer VaccineVoltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement [...]
Voltron Therapeutics Publishes Letter to Shareholders
Voltron Therapeutics Publishes Letter to Shareholders